Protein Purification
ABclonal Technology XK Rabbit pAb
This locus controls the synthesis of the Kell blood group precursor substance (Kx). Mutations in this gene have been associated with McLeod syndrome, an X-linked, recessive disorder characterized by abnormalities in the neuromuscular and hematopoietic systems. The encoded protein has structural characteristics of prokaryotic and eukaryotic membrane transport proteins.
Bioss Dengue virus
Dengue virus Primary Antibody Unconjugated Host Species Mouse Target Species Clonality Monoclonal Applications ELISA Concentration 100 g/ml Size 100 ug Storage Buffer PBS (pH 7 2) with 0 1% azide
Abcam Gefitinib, EGFR tyrosine kinase inhibitor, 50MG
MW 446.9 Da, Purity >98%. Orally active, potent, selective EGFR (Epidermal growth factor receptor) tyrosine kinase inhibitor (IC₅₀ = 33 nM). Inhibits EGF-stimulated EGFR autophosphorylation and inhibits tumor growth in vivo. Enhances efficacy of cytotoxic agents. Inhibits growth factor production and angiogenesis. Clinically useful anticancer agent.
The product is subject to the following: Abcam Restricted Use Statement
Medchemexpress LLC KRAS G12D inhibitor 1 | 2621928-43-4 | MFCD00237621 | 98.5% | 582.64 g/mol | C33H32F2N6O2 | 5 MG
KRAS G12D inhibitor 1 is a potent, selective small-molecule inhibitor of the oncogenic KRAS G12D mutant for preclinical research. It demonstrates subnanomolar biochemical potency and cellular activity and is supplied as solid material and as a DMSO stock for laboratory use.
- Potent inhibition of KRAS G12D (IC50 = 0.4 nM in biochemical assay).
- Inhibits KRAS G12D-mediated ERK phosphorylation (IC50 = 0.8 nM in cellular assay).
- Suitable for preclinical research of cancers with KRAS G12D mutations.
- Available as solid (1 mg, 5 mg, 10 mg) and 10 mM 1 mL DMSO stock.
- Molecular formula C33H32F2N6O2; molecular weight 582.64 g/mol.
- High purity (≈98.5%).
Cayman Chemical GAPDH InhIbItr Compound F8 1mg
A covalent inhibitor of GAPDH (IC50 = 39.31 µM); decreases viability of, and glucose metabolism in, HEK293 cells in a concentration-dependent manner
Ubpbio A covalent inhibitor of 3CL protease. A component of Paxlovid used for the treatment of COVID 19. CAS# 26288280-40-8, > 99% purity
PF-07321332 is an orally active covalent inhibitor of the 3C-like protease by direct binding of the catalytic cysteine 145. 3CL protease cleaves polyproteins 1a and 1ab of SARS-CoV-2, a step required for reproduce the virus. The PF-07321332/ritonavir combination drug (trade name Paxlovid) is efficient for the treatment of COVID-19 as, in November 2021, Pfizer announced phase 2/3 clinal trial results that the drug treatment reduced 89% in hospitalizations when given within three days after symptom onset. This product is for research use only.
Cayman Chemical CDK2 InhIbItr 73 10mg
A Cdk2 inhibitor (IC50 = 0.044 µM); selective for Cdk2 over Cdk1, Cdk4, Cdk7, and Cdk9 at 100 µM
ACROBiosystems GMP ActiveMax Human T cell Activation/Expansion CD3/CD28 Beads
GMP ActiveMax Human T cell Activation/Expansion CD3/CD28 Beads are uniform 5.5 μm of magnetic beads coated with an optimized mixture of GMP grade mouse monoclonal antibodies against the CD3 and CD28, mimicking in vivo stimulation by APCs.GMP ActiveMax Human T cell Activation/Expansion CD3/CD28 Beads are Manufactured under a GMP compliance factory with animal free raw materials, and tested under GMP guidelines.
Hampton Research STOCKOPT AMPD #06 PH 8.3
HR2-254-06/StockOptions AMPD #06, 1.0 M AMPD pH 8.3, 185 ml. Please note items from this supplier are non-returnable.
Hampton Research STOCKOPT ADA #08 PH 6.3
HR2-255-08/StockOptions ADA #08, 1.0 M ADA pH 6.3, 185 ml. Please note items from this supplier are non-returnable.